Hinge Health, Inc. (HNGE) financial statements and ratios from SEC XBRL: revenue $0.7B (TTM), net margin -89.9%, revenue growth 53.0% YoY, P/E 67.7. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (latest FY) | $587.86M |
| Revenue (TTM) | $0.7B |
| Net Margin | -89.9% |
| Return on Equity | 31.7% |
| Operating Margin (TTM) | 13.0% |
| Current Ratio | 1.34 |
| Net Debt / EBITDA | -4.0 |
| Revenue Growth (YoY) | 53.0% |
| EPS Growth (YoY) | -104.2% |
| FCF Growth (YoY) | 405.7% |
| P/E Ratio | 67.7 |
| EV / EBITDA | 72.0 |
| Price / Book | 21.46 |
| Price / Sales | 10.26 |
| FCF Yield | 3.9% |
| Altman Z-Score | 1.79 (distress) |
| Industry P/E (Business Services) | 24.7 |
| Sector P/E (Technology) | 29.5 |
HNGE overview · HNGE earnings · HNGE KPIs · HNGE documents · HNGE ownership · HNGE peers
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.